Clinical Trial Update: A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a decentralized, randomized Phase 2 study evaluating the efficacy and safety of Paxlovid (nirmatrelvir/ritonavi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• PAXLOVID (Nirmatrelvir and ritonavir)

Snippet

Sponsor: Harlan M Krumholz | Conditions: Long COVID | Phase 2 | Status: COMPLETED